The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital transactions, and ignores key realities of the marketplace,” according to an analysis submitted to the agency Friday for a series of FTC hearings on Competition and Consumer Protection in the 21st Century. Performed for the AHA by Charles River Associates in conjunction with antitrust counsel at Wilson Sonsini Goodrich & Rosati, the analysis describes “serious flaws” in the supply and demand models that the FTC uses to evaluate the competitive effects of hospital transactions. “The Commission’s approach has substantial negative ramifications for U.S. consumers,” AHA said. “These include impeding the ability of hospitals and health care systems to develop more efficient platforms to care for tens of millions of Americans. The FTC’s approach also is placing hospitals at a serious disadvantage relative to the many new entrants to health care.”

Related News Articles

Headline
A replay of the Hospital Capacity Management Consortium’s Spring Symposium is now available. The event, for health care capacity management professionals,…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
A blog by the AHA and Press Ganey shares insights from leaders of seven health care systems on balancing the demands of delivering personalized, high-quality…
Perspective
Public
One year ago, a nurse at Children’s Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget. Kayla…
Headline
Achieving operational and survey readiness on day one is an issue that many health care facilities professionals continue to grapple with, according to…
Headline
Claire Zangerle, DNP, R.N., chief executive officer of the American Organization for Nursing Leadership and senior vice president and chief nurse executive of…